Where science and innovation become investable.
Clinical insight, research depth and founder experience to uncover the investable moat behind complex science and connect exceptional talent with the right capital across global markets.
About Munteh Strategy
Founded by Diana Munteh, MD, Munteh Strategy brings together clinical expertise, scientific depth, investment experience and firsthand founder perspective. Diana is a radiation oncology resident, investor, Harvard-published medical researcher and former biotech founder with more than five years of experience across the startup and venture ecosystem. Her work is grounded in a rare ability to understand both the scientific complexity behind innovation and the commercial requirements that turn promising ideas into credible, investable and scalable ventures.
With clinical experience spanning three continents and more than six major innovation hubs, from Tokyo to New York, she brings a truly international perspective to science, venture building and capital deployment. As Healthcare Investment Lead at Bright Future Club, a Berlin-based angel syndicate, she identifies high-potential companies, evaluates the scientific and commercial moat behind complex technologies and supports founders in strengthening their strategic positioning, investor readiness and path to market.
Munteh Strategy exists to connect exceptional talent with the capital, expertise and global networks required to scale. Its mission is equally focused on helping founders translate scientific promise into investable opportunity and helping investors deploy capital with greater conviction across markets, geographies and innovation ecosystems.
Global innovation should be able to access global capital, and global capital should be able to reach the strongest opportunities wherever they emerge. Munteh Strategy builds that bridge.
Global Reach
Frankfurt is home base. The pins below mark where the network reaches.
Frankfurt is home base, connected with Berlin, Amsterdam, Montpellier, New York, Tokyo, Hong Kong, Dubai, Lagos and Yaounde.
Clinical substance and investable narrative don't always speak the same language. Munteh Strategy sits at the point where they have to.
Investors & Family Offices
Munteh Strategy supports international family offices, angel investors and investment teams evaluating healthcare, biotech and medical innovation across borders.
The focus is on the questions that financial models and pitch decks often leave unanswered. Is the science credible? Does the solution address a meaningful clinical need? Can it integrate into real healthcare workflows? Is the technology genuinely differentiated? Does the team have a realistic path from validation to adoption and scale?
Investment Assessment
Munteh Strategy provides an independent view of the clinical relevance, scientific credibility and commercial potential of live opportunities. Complex research, clinical data and technical claims are translated into clear investment implications, key risks and practical diligence questions.
Scientific and Commercial Moat
Investors receive a clearer view of where defensibility truly lies, whether in proprietary science, clinical validation, data access, workflow integration, intellectual property, regulatory positioning or specialist market access.
Founder and Market Evaluation
Munteh Strategy assesses whether founding teams can convert technical strength into commercial execution and whether an opportunity can succeed across different healthcare systems, regulatory environments and international markets. This is particularly valuable for investors exploring opportunities connected to Africa, Asia and globally linked innovation ecosystems.
Strategic Introductions
Where relevant, investors are connected with founders, clinicians, researchers, operators and ecosystem partners who can strengthen diligence, validate assumptions or support portfolio growth.
The goal is not simply to facilitate introductions, but to connect the right capital with the right expertise and the right opportunities across international markets.
Portfolio Support
Support can continue after investment. Munteh Strategy helps portfolio companies strengthen their scientific positioning, refine their strategic narrative, communicate more effectively with investors and partners, and prepare for engagement with clinical stakeholders.
For investors seeking more than deal flow, Munteh Strategy provides the clinical judgement, scientific depth, international connectivity and strategic support required to identify stronger opportunities and deploy capital with greater confidence.
Discuss Your Investment LensFounders & Researchers
Munteh Strategy supports biotech, medtech and digital health founders, as well as researchers preparing to translate scientific innovation into credible, fundable and commercially relevant ventures.
The focus is on turning complex science into a clear strategic narrative that investors, partners and clinical stakeholders can understand and trust.
Investor Narrative and Pitch Positioning
Munteh Strategy helps founders structure pitch decks, sharpen their value proposition and communicate the investment case behind their technology. This includes clarifying the unmet need, scientific differentiation, commercial opportunity, business model and path to scale.
Research Commercialisation
Researchers receive support in framing scientific discoveries for commercial application. Munteh Strategy helps identify potential use cases, target markets, strategic partners and the evidence required to move from research promise to venture readiness.
Scientific and Commercial Positioning
Founders are supported in defining where their true moat lies and how to communicate it convincingly. This may include proprietary science, clinical validation, data access, intellectual property, workflow integration or specialist expertise.
Investor and Partner Readiness
Munteh Strategy prepares founders for conversations with investors, strategic partners and clinical stakeholders. This includes refining messaging, anticipating critical questions and presenting complex evidence with clarity and confidence.
Strategic Visibility and Introductions
Where relevant, founders and researchers are connected with investors, clinicians, operators, academic partners and ecosystem leaders who can strengthen validation, accelerate commercialisation or support future growth.
For founders and researchers building complex innovation, Munteh Strategy provides the strategic clarity, scientific positioning and international connectivity required to move from promising research to credible investment opportunity.
Strengthen Your Venture NarrativeSelected Publications
Dichter AA, Winklmeier F, Munteh D, et al. Porin A and alpha/beta-hydrolase are necessary and sufficient for hemolysis induced by Bartonella bacilliformis. Nature Communications. 2025 Nov 28;16(1):10809.
View on PubMed →Verheijen EJA, Kapogiannis T, Munteh D, et al. Artificial intelligence for segmentation and classification in lumbar spinal stenosis: an overview of current methods. European Spine Journal. 2025 Mar;34(3):1146 to 1155.
View on PubMed →Thirugnanam A, Donthineni K, Mammi M, Munteh D, et al. Chimeric antigen receptor T-cell therapy and immune effector cell-associated neurotoxicity syndrome: a meta-analysis. Critical Reviews in Oncology/Hematology. 2025 Dec 23;218:105095.
View on PubMed →
Healthcare Investment Lead, Bright Future Club
Diana is Healthcare Investment Lead at Bright Future Club, a Berlin-based angel syndicate, where she evaluates high-potential healthcare opportunities alongside founders and co-investors.
She stays open to connecting through this role as well, whether that means a co-investment conversation or an introduction for a portfolio company.
Connect as an InvestorRegular writing on healthcare innovation.
Clinical translation, startups, research commercialisation, investment logic and emerging ecosystems, written for people building, funding and translating healthcare innovation around the globe.
Follow Munteh Strategy on Substack for new essays as they are published.
Read on SubstackBook the first strategic call.
For startups, researchers and investors. Pick a time below, the call happens right here, no separate booking site to juggle.
Frankfurt am Main, Germany